Shares of pharmaceutical major Cipla today fell over 2 per cent ahead of earnings.
The stock fell as much as 2.1 per cent.
The company will report December quarter earnings later in the day.
Net income is expected to miss estimates. It may come in at Rs 414 crore ($61 million) against the expected Rs 428 crore, according to Thomson Reuters Starmine SmartEstimates.
The stock had fallen 14.45 per cent this year, as of Tuesday’s close ($1 = 67.9250 Indian rupees)